FindTrial
Sign In

Heritability in Oropharynx Cancer

Evaluating The Role Of Genetic Susceptibility For Oropharynx Cancer In Indian Origin Population: a case-control study using the candidate gene approach

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/07/020299
Enrollment
1200
Registered
2019-07-22
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C109- Malignant neoplasm of oropharynx,unspecified

Interventions

None listed

Sponsors

Department of Health Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All new histopathologically confirmed primary oropharynx cancer cases. Oropharynx cancer, cancer case definition (ICD-O-3):- Anterior wall (glossoepiglottic area) Base of tongue (C01), Vallecula(C10.0), Lateral wall of oropharynx(C10.2) Tonsil (C09.9), Tonsilar fossa(C09.0), and tonsilar (faucial) pillar (C09.1) Posterior wall of oropharynx(C10.3) Superior wall of oropharynx Inferior surface of the soft palate (C05.1) Uvula (C05.2) Male, female Date of diagnosis less than or equal to 6 months from the date of enrollment Age between 20-65 years A resident of India for at least one year

Exclusion criteria

Exclusion criteria: Malignancies other than oropharynx Pregnant females Date of diagnosis more than 6 months from the date of enrollment Age less than 20 years and more than 65 Non-resident of India

Design outcomes

Primary

MeasureTime frame
Oropharynx cancerTimepoint: 6 months—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactDr Sharayu Mhatre

Centre For Cancer Epidemiology, Tata Memorial Centre

mhatresharayu@gmail.com9820958946

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026